Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

Use of Preoperative MRI to Predict Vestibular Schwannoma Intraoperative Consistency and Facial Nerve Outcome
Hoover, Jason M. , Driscoll, Colin L. W., Link, Michael , Copeland, William , Morris, Jonathan M.

Journal of Neurological Surgery Part B: Skull Base | May 22, 2013 | Volume: 74 | Issue: 06 | Pages: 347-350

10.1055/s-0033-1347369 | PMID 24436936 Get It

Prognostic Value of Complete Blood Count and Electrolyte Panel during Emergency Department Evaluation for Acute Ischemic Stroke
Ganti, Latha , Gilmore, R.M. , Weaver, Amy L. , Brown, Robert D.

ISRN Stroke | May 22, 2013 | Volume: 2013 | Issue: No issue available | Pages: 1-5

10.1155/2013/974236 Get It

Objective. To determine whether routine laboratory parameters are predictors of early mortality after acute ischemic stroke (AIS). Methods. The cohort consisted of 522 consecutive patients with AIS presenting to the emergency department (ED) at a tertiary referral center during a 27-month period, residing within the surrounding ten counties. Serum laboratory values were obtained for all patients and categorized according to whether the levels were low, normal, or high. These laboratory results were evaluated as potential predictors of 90-day mortality using Cox proportional hazards models. The associations were summarized by calculating risk ratios (RRs) and 95% confidence intervals (CI). Results. The presence of elevated white blood cell count (RR 2.2, 95% CI 1.5–3.4), low bicarbonate (RR 4.2, 95% CI 2.6–6.7), low calcium (RR 2.9, 95% CI 1.4–5.9), and high glucose (RR 1.3, 95% 1.1–1.6) were each univariately associated with significantly higher mortality within the first 90 days. Based on fitting a multivariate Cox regression model, elevated white blood cell count, low bicarbonate, and high glucose were each identified as being jointly associated with early mortality (). Conclusion. Early leukocytosis, acidosis, and hyperglycemia and hypocalcemia in AIS appear to be associated with early mortality. Whether addressing these factors will impact survival remains to be investigated.
Physical Activity Among Somali Men in Minnesota
Mohamed, Ahmed A. , Hassan, Abdullahi, Weis, Jennifer A., Sia, Irene G. , Wieland, Mark L. , Sia, Irene G

American Journal of Men's Health | May 22, 2013 | Volume: 8 | Issue: 1 | Pages: 35-44

10.1177/1557988313489132 | PMID 23697961 Get It

Immigrants and refugees arrive to the United States healthier than the general population, but this advantage declines with increasing duration of residence. One factor contributing to this decline is suboptimal physical activity, but reasons for this are poorly understood. Persons from Somalia represent the largest African refugee population to the United States, yet little is known about perceptions of physical activity among Somali men. Somali members of a community-based participatory research partnership implemented three age-stratified focus groups and three semistructured interviews among 20 Somali men in Rochester, Minnesota. Team-based inductive analysis generated themes for barriers and facilitators to physical activity. Barriers to physical activity included less walking opportunities in the United States, embarrassment about exercise clothing and lack of familiarity with exercise equipment/modalities, fear of harassment, competing priorities, facility costs, transportation, and winter weather. Facilitators to physical activity included high knowledge about how to be active, success stories from others in their community as inspiration, and community cohesion. Findings may be used to derive interventions aimed to promote physical activity among Somali men in the United States.
Determinants of fluoroscopy time for invasive coronary angiography and percutaneous coronary intervention: Insights from the NCDR®
Fazel, Reza , Curtis, Jeptha P. , Wang, Yongfei , Tsai, Thomas T., Chen, Jersey , Shah, Nilay D. , Nallamothu, Brahmajee K. , Einstein, Andrew Jeffrey , Smith‐Bindman, Rebecca , Krumholz, Harlan M.

Catheterization and Cardiovascular Interventions | May 22, 2013 | Volume: 82 | Issue: 7 | Pages: 1091-1105

10.1002/ccd.24996 | PMID 23703793 Get It

ABSTRACTObjectivesIdentifying the distributions and determinants of fluoroscopy time for invasive coronary angiography (ICA) and percutaneous coronary intervention (PCI).BackgroundICA and PCI are significant contributors to radiation exposure from medical imaging in the US. Fluoroscopy time is a potentially modifiable determinant of radiation exposure for these procedures, but has not been well characterized in contemporary practice.MethodsWe evaluated the distribution of fluoroscopy time in patients undergoing ICA and/or PCI in the CathPCI Registry®, stratifying patients by numerous clinical scenarios. Hierarchical models were used to determine patient, procedure, operator and hospital‐level factors associated with fluoroscopy time for these procedures.ResultsOur study included a total of 3,295,348 ICA and PCI procedures performed by 9,600 operators from January 2005 through June 2009. There was wide variation in fluoroscopy times for these procedures with median [IQR] fluoroscopy times of 2.6 [1.7–4.5] minutes for ICA, 6.7 [4.2–10.8] minutes for ICA in patients with prior coronary artery bypass grafting (CABG), 10.1 [6.0–17.4] minutes for PCI, 10.7 [7.0–16.9] minutes for PCI with ICA, and 16.0 [10.6–24.0] minutes for PCI and ICA in patients with prior CABG. Prolonged fluoroscopy times (>30 minutes) were rare for ICA, but occurred in 6.7% of PCIs and 14.7% of PCIs in patients with prior CABG. After accounting for patient characteristics and procedure complexity, operator and hospital‐level factors explained nearly 20% of the variation in fluoroscopy time.ConclusionsFluoroscopy times vary widely during ICA and PCI with operator and hospital‐level factors contributing substantially to these differences. A better understanding of potentially modifiable sources of this variation will elucidate opportunities for enhancing the radiation safety of these procedures. © 2013 Wiley Periodicals, Inc.
In Reply:
Turner, J. , Cole, Daniel J.

Anesthesiology | May 22, 2013 | Volume: 118 | Issue: 6 | Pages: 1484-1484

10.1097/aln.0b013e318291d923 Get It

Anterior Segment Imaging in Glaucoma
Salim, Sarwat , Dorairaj, Syril

Seminars in Ophthalmology | May 22, 2013 | Volume: 28 | Issue: 3 | Pages: 113-125

10.3109/08820538.2013.777749 | PMID 23697615 Get It

Attributes Associated with Patient Perceived Outcome in an Academic Chronic Pain Clinic
Trentman, Terrence L. , Chien, James J., Rosenfeld, David M. , Gorlin, Andrew , Seamans, David P. , Freeman, John A., Wilshusen, Laurie , Chang, Yu‐Hui

Pain Practice | May 22, 2013 | Volume: 14 | Issue: 3 | Pages: 217-222

10.1111/papr.12077 | PMID 23692280 Get It

AbstractObjectivesPatient satisfaction is tied to outcome, but there is scant literature on the relationship of patient perceived outcome and attributes of the pain clinic visit, including the patient interaction with the pain management specialist. The primary purpose of this study is to identify attributes of the patient–provider interaction most strongly associated with patient perceived outcome of their clinic visit. The secondary aim is to correlate patient perceived outcome with patient self‐rated overall health.MethodsA patient satisfaction survey conducted via phone approximately 3 weeks after the patient's pain clinic visit.ResultsThe response rate was 60.2%; 987 patient surveys collected between 2006 and 2010 were used in the analysis. Four factors were significantly associated with the outcome: (1) Explanations by the physician of the patient's condition and treatment, (2) clear instructions regarding post‐appointment activities, (3) knowing the patient as a person, and (4) the patient's self‐rated health. In terms of the secondary objective, those who answered very good/excellent regarding their self‐rated health had an 87% increased odds of better (very good/excellent) outcome of their pain clinic visit (or 1.87 times the odds of better outcome) compared with those who answered poor/fair/good.ConclusionsOur results suggest that pain physicians may positively impact patient perceived outcomes of clinic visits by explaining the patient's condition and treatment, providing instructions, and taking the time to understand the patient and their values.
Diagnosis and treatment of temporomandibular disorders: an ethical analysis of current practices
Reid, Kevin, Greene, Charles S.

Journal of Oral Rehabilitation | May 22, 2013 | Volume: 40 | Issue: 7 | Pages: 546-561

10.1111/joor.12067 | PMID 23691977 Get It

Summary The defining characteristic of a profession – and especially a health‐care profession – is that the behaviour of its members is proscribed by a formal code of ethics. The main purpose of such codes is to guide practitioners' interactions with patients, assuring that patient interests are protected. In other words, the ethical code requires practitioners to place their patients' needs for proper diagnosis and appropriate treatment ahead of their own needs for income and advancement. The dental profession has a code of ethics that was developed by the American Dental Association many years ago; in most clinical situations, determination of proper behaviour is self‐evident. However, the field of temporoman‐dibular disorders ( TMD s) has been the subject of considerable controversy for over half a century, and many people have argued that this makes it impossible to evaluate various approaches to treatment of TMD s within an ethical framework. In this article, the authors argue that the large volume of scientific evidence in the contemporary TMD literature provides an ethical framework for the diagnosis and treatment of patients with TMD s within a biopsychosocial medical model. They present a summary of the research with contemporary scientific integrity, which has produced that information over a period of many years. Based on that research, they conclude that dentists may provide conservative and reversible treatments that will be successful for most TMD s and in doing so will comply with the profession's code of ethics. Conversely, the authors claim that those dentists who continue to follow the older mechanistic models of TMD aetiology and treatment are not only out of step scientifically, but are placing their patients' welfare at risk by providing unnecessary irreversible bite‐changing and jaw‐repositioning interventions. Therefore, debate of these issues should not be solely focused on scientific merit, but also upon the compelling ethical obligations that dentists have as a result of the contemporary scientific literature regarding TMD s.
Lineage Relationship of Gleason Patterns in Gleason Score 7 Prostate Cancer
Kovtun, Irina V. , Cheville, John C. , Johnson, Sarah H. , Zarei, Shabnam , Kosari, Farhad , Sukov, William R. , Karnes, R. Jeffrey , Vasmatzis, George , Murphy, Stephen J.

Cancer Research | May 22, 2013 | Volume: 73 | Issue: 11 | Pages: 3275-3284

10.1158/0008-5472.can-12-2803 | PMID 23695551 Get It

Abstract Gleason score 7 (GS7) prostate cancer [tumors with both Gleason patterns 3 (GP3) and 4 (GP4)] portends a significantly more aggressive tumor than Gleason score 6 (GS6). It is, therefore, critical to understand the molecular relationship of adjacent GP3 and GP4 tumor cell populations and relate molecular abnormalities to disease progression. To decipher molecular relatedness, we used laser capture microdissection (LCM) and whole-genome amplification (WGA) to separately collect and amplify DNA from adjacent GP3 and GP4 cell populations from 14 cases of GS7 prostate cancer. We then carried out massively parallel mate-pair next generation sequencing (NGS) to examine the landscape of large chromosomal alterations. We identified four to 115 DNA breakpoints in GP3 and 17 to 480 in GP4. Our findings indicate that while GP3 and GP4 from the same tumor each possess unique breakpoints, they also share identical ones, indicating a common origin. Approximately 300 chromosomal breakpoints were localized to the regions affected in at least two tumors, whereas more than 3,000 were unique within the set of 14 tumors. TMPRSS2–ERG was the most recurrent rearrangement present in eight cases, in both GP3 and GP4. PTEN rearrangements were found in five of eight TMPRSS2–ERG fusion–positive cases in both GP3 and GP4. Hierarchical clustering analysis revealed that GP3 has greater breakpoint similarity to its partner GP4 compared with GP3 from different patients. We show evidence that LCM, WGA, and NGS of adjacent tumor regions provide an important tool in deciphering lineage relationships and discovering chromosomal alterations associated with tumor progression. Cancer Res; 73(11); 3275–84. ©2013 AACR.
Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk‐stratification, and management
Tefferi, Ayalew

American Journal of Hematology | May 22, 2013 | Volume: 88 | Issue: 6 | Pages: 507-516

10.1002/ajh.23417 | PMID 23695894 Get It

Disease OverviewPolycythemia Vera (PV) and essential thrombocythemia (ET) are myeloproliferative neoplasms (MPN) primarily characterized by erythrocytosis and thrombocytosis, respectively. Other disease features include leukocytosis, splenomegaly, thrombohemorrhagic complications, vasomotor disturbances, pruritus and a small risk of disease progression into acute myeloid leukemia or myelofibrosis.DiagnosisAlmost all patients with PV harbor aJAK2mutation. When PV is suspected, the presence of aJAK2mutation highly suggests the diagnosis and its absence, combined with normal or increased serum erythropoietin level, excludes the diagnosis. Differential diagnosis of ET should include reactive thrombocytosis, chronic myeloid leukemia, prefibrotic myelofibrosis and RARS‐T (refractory anemia with ring sideroblasts associated with marked thrombocytosis). AJAK2mutation is found in 50–70% of patients with ET, myelofibrosis or RARS‐T and is capable of distinguishing reactive from clonal thrombocytosis.Risk StratificationCurrent risk stratification in PV and ET is designed to estimate the likelihood of thrombotic complications: high‐risk is defined by the presence of age >60 years or presence of thrombosis history; low‐risk is defined by the absence of both of these two risk factors. Recent data considersJAK2V617F and cardiovascular (CV) risk factors as additional risk factors for thrombosis. Presence of extreme thrombocytosis (platelet count >1,000 × 109/L) might be associated with acquired von Willebrand syndrome (AvWS) and, therefore, risk of bleeding. Risk factors for shortened survival in both PV and ET include advanced age, leukocytosis, and history of thrombosis.Risk‐Adapted TherapySurvival is near‐normal in ET and reasonably long in PV. The 10‐year risk of leukemic/fibrotic transformation is <1%/1% in ET and <3%/10% in PV. In contrast, the risk of thrombosis exceeds 20%. The main goal of therapy is therefore to prevent thrombohemorrhagic complications. In low risk patients, this is effectively and safely accomplished by the use of low‐dose aspirin in both PV and ET and phlebotomy (hematocrit target of <45%) in PV. In high risk patients, treatment with hydroxyurea is additionally recommended, although not mandated in older patients withoutJAK2V617F or CV risk factors. Treatment with busulfan or interferon‐α is usually effective in hydroxyurea failures. Screening for clinically significant AvWS is recommended before administrating aspirin in the presence of extreme thrombocytosis. Am. J. Hematol. 88:508–516, 2013. © 2013 Wiley Periodicals, Inc.